Objective: To determine the reasons related to the cancellation of the surgeries of the patients who were taken to the operating table for pars plana vitrectomy and the precautions needed to be taken to prevent them. Material and Methods: Twenty-five patients who were planned to be operated on for different retinal diseases between January 2018 and June 2019, but whose surgeries were canceled due to medical reasons, were included in this study. Demographic data of the patients and indications of surgery and causes of operation cancellation were analyzed. Results: 11 (44%) of the patients were female and 14 (56%) were male, and 15 (60.2%) of them needed to have a vitreoretinal surgery in the right eye while the other 10 (39.8%) in the left eye. Surgical indications were diabetic intravitreal hemorrhage in 8 (32%) cases, retinal detachment in 7 (28%) cases, cataract, and epiretinal membrane in 5 (20%) cases, intraocular lens dislocation in 4 (16%) eyes and 1 (4%) case with retinal detachment and prephytisis. 16 (64%) of the patients had hypertension (HT), 11 (44%) of the patients had diabetes mellitus, 7 (28%) of the patients had coronary heart disease (CHD), 2 (8%) of the patients had obesity, 2 (8%) of the patients had a chronic renal failure and 1 (4%) of the patients had epilepsy. The most common medical reason for cancellation of the surgery was HT and CHD (64%). Conclusion: Careful assessment of the reasons for cancellation will lessen time loss and financial losses for both the patient and the healthcare system.
Keywords: Pars plana vitrectomy; systemic disease; operating room
Amaç: Pars plana vitrektomi (PPV) için ameliyathaneye alınan ancak ameliyatı ertelenen hastaların ameliyatlarının ertelenme sebepleri ve bunlara yönelik alınabilecek önlemleri tespit etmek. Gereç ve Yöntemler: Ocak 2018-Haziran 2019 tarihleri arasında farklı retina hastalıkları nedeniyle ameliyat edilmesi planlanan ancak tıbbi nedenlerle ameliyatları iptal edilen 25 hasta bu çalışmaya dahil edildi. Hastaların demografik bilgileri ve ameliyat olma endikasyonları ve ameliyatlarının ertelenme sebepleri analiz edildi. Bulgular: Hasta grubunda 11'i (%44) kadın ve 14'ü (%56) erkek ve 15'inin (%60,2) sağ gözünde, 10'unun (%39,8) sol gözünde vitreoretinal cerrahi ihtiyacı vardı. Ameliyat endikasyonu 8 (%32) hastada diyabetik intravitreal hemoroji, 7 (%28) hastada retina dekolmanı, 5 (%20) hastada katarakt ve epiretinal membran, 4 (%16) hastada göz içi lens dislokasyonu ve 1 (%4) hastada retina dekolmanlı prefitizik göz idi. Öz geçmişlerinde 16 (%64) hastada hipertansiyon (HT), 11 (%44) hastada diabetes mellitus, 7 (%28) hastada koroner kalp hastalığı (KKH), 2 (%8) hastada obezite, 2 (%8) hastada kronik böbrek yetersizliği ve 1 (%4) hastada epilepsi vardı. En çok karşılaşılan ameliyat erteleme sebebi HT ve KKH (%64) idi. Sonuç: Ameliyat erteleme sebeplerini dikkatli şekilde değerlendirmek ve daha fazla önlem almak hem hasta hem de sağlık sisteminin zaman ve diğer kayıplarını azaltacaktır.
Anahtar Kelimeler: Pars plana vitrektomi; sistemik hastalık; ameliyathane
- Znaor L, Medic A, Binder S, Vucinovic A, Marin Lovric J, Puljak L. Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments. Cochrane Database Syst Rev. 2019;3(3):CD009562. [Crossref] [PubMed] [PMC]
- Ghoraba HH, Leila M, Zaky AG, Wasfy T, Maamoun Abdelfattah H, Elgemai EM, et al. Results of pars plana vitrectomy for different types of macular holes. Clin Ophthalmol. 2021;15:551-7. [Crossref] [PubMed] [PMC]
- Kumar V, Kumawat D, Bhari A, Chandra P. Twenty-five-gauge pars plana vitrectomy in complex retinal detachments associated with giant retinal tear. Retina. 2018;38(4):670-7. [Crossref] [PubMed]
- Mahmoudzadeh R, Israilevich R, Salabati M, Hsu J, Garg SJ, Regillo CD, et al. Pars plana vitrectomy for idiopathic epiretinal membrane: OCT biomarkers of visual outcomes in 322 eyes. Ophthalmol Retina. 2022;6(4):308-17. [Crossref] [PubMed]
- Jackson TL, Donachie PH, Sparrow JM, Johnston RL. United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: report 1; case mix, complications, and cataract. Eye (Lond). 2013;27(5):644-51. [Crossref] [PubMed] [PMC]
- Smilowitz NR, Berger JS. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA. 2020;324(3):279-90. [Crossref] [PubMed]
- Bierle DM, Raslau D, Regan DW, Sundsted KK, Mauck KF. Preoperative evaluation before noncardiac surgery. Mayo Clin Proc. 2020;95(4):807-22. [Crossref] [PubMed]
- Alabi RO, Turnbull ZA, Coombs PG, Wu Y, Orlin A, Chan RP, et al. Assessing the value of preoperative medical clearance in patients with primary rhegmatogenous retinal detachment. Clin Ophthalmol. 2019;13:1711-8. [Crossref] [PubMed] [PMC]
- Yau GL, Silva PS, Arrigg PG, Sun JK. Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol. 2018;33(1):126-33. [Crossref] [PubMed]
- Haseeb U, Aziz-Ur-Rehman, Haseeb M. Visual outcomes of pars plana vitrectomy alone or with intravitreal bevacizumab in patients of diabetic vitreous haemorrhage. J Coll Physicians Surg Pak. 2019;29(8):728-31. [Crossref] [PubMed]
- Brown GC, Brown MM, Chaudhry I, Stein JD. Opportunities to reduce potential bias in ophthalmic cost-utility analysis. JAMA Ophthalmol. 2021;139(4):389-97. [Crossref] [PubMed] [PMC]
- Brown MM, Brown GC, Lieske HB, Lieske PA. Preference-based comparative effectiveness and cost-effectiveness: a review and relevance of value-based medicine for vitreoretinal interventions. Curr Opin Ophthalmol. 2012;23(3):163-74. [Crossref] [PubMed]
- Chang JS, Smiddy WE. Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes. Ophthalmology. 2014;121(9):1720-6. [Crossref] [PubMed] [PMC]
- Waseem T, Reinhart C, Wagner AL, Kapoor KG. Updated cost-effectiveness of intravitreal ocriplasmin for vitreomacular adhesion and macular hole. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):e240-e8. [Crossref] [PubMed]
- Elhusseiny AM, Yannuzzi NA, Smiddy WE. Cost analysis of pneumatic retinopexy versus pars plana vitrectomy for rhegmatogenous retinal detachment. Ophthalmol Retina. 2019;3(11):956-61. [Crossref] [PubMed]
- Belin PJ, Yannuzzi NA, Wagley S, Smiddy WE, Ryan EH. Cost analysis of scleral buckle, pars plana vitrectomy, and pars plana vitrectomy with scleral buckle for retinal detachment repair. Retina. 2022;42(1):33-7. [Crossref] [PubMed]
- Nicod E, Jackson TL, Grimaccia F, Angelis A, Costen M, Haynes R, et al. Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. Eur J Health Econ. 2016;17(8):991-9. [Crossref] [PubMed] [PMC]
- Yannuzzi NA, Chang JS, Brown GC, Smiddy WE. Cost-utility of evaluation for posterior vitreous detachment and prophylaxis of retinal detachment. Ophthalmology. 2018;125(1):43-50. [Crossref] [PubMed]
- Simanjuntak GW, Djatikusumo A, Adisasmita A, Nadjib M, Mailangkay H, Hussain N. Cost analysis of vitrectomy under local versus general anesthesia in a developing country. Clin Ophthalmol. 2018;12:1987-91. [Crossref] [PubMed] [PMC]
- Atik A, Barton K, Azuara-Blanco A, Kerr NM. Health economic evaluation in ophthalmology. Br J Ophthalmol. 2021;105(5):602-7. [Crossref] [PubMed]
- Framme C, Franz D, Mrosek S, Helbig H, Sachs HG. Kostenkalkulation für die Behandlung von offenen Augenverletzungen in der DRG C01Z an einer Universitäts-Augenklinik [Cost calculations for treating penetrating eye injuries within the DRG C01Z at a university eye hospital]. Ophthalmologe. 2008;105(10):936-42. German. [Crossref] [PubMed]
- Trujillo-Sanchez GP, Gonzalez-De La Rosa A, Navarro-Partida J, Haro-Morlett L, Altamirano-Vallejo JC, Santos A. Feasibility and safety of vitrectomy under topical anesthesia in an office-based setting. Indian J Ophthalmol. 2018;66(8):1136-40. [Crossref] [PubMed] [PMC]
- Bricout M, Feldman, Rochepeau C, Hafidi M, Labeille E, Cornut PL. Chirurgie vitréo rétinienne en ambulatoire sans examen du lendemain: faisabilité et acceptabilité [Outpatient vitreoretinal surgery without next-day examination: Feasibility and acceptability]. J Fr Ophtalmol. 2018;41(9):852-6. [Crossref] [PubMed]
- Shalwala A, Hwang RY, Tabing A, Sternberg P Jr, Kim SJ. The value of preoperative medical testing for vitreoretinal surgery. Retina. 2015;35(2):319-25. [Crossref] [PubMed]
- Cornut PL, Soldermann Y, Robin C, Barranco R, Kerhoas A, Burillon C. Optimisation de l'impact financier du passage à la vitrectomie transconjonctivale et à la phakoémulsification par mini-incision [Optimizing the financial impact of transitioning to transconjunctival vitrectomy and microincisional phacoemulsification]. J Fr Ophtalmol. 2013;36(10):843-51. French. [Crossref] [PubMed]
- Cheong Y, Kim N, Kim M, Son HJ, Huh J, Kang SS, Lim SY, Hwang B. Postoperative pulmonary edema following vitrectomy in patients with ischemic heart disease and diastolic dysfunction in the post-anesthetic care unit: Two case reports. Medicine (Baltimore). 2020;99(38):e22296. [Crossref] [PubMed] [PMC]
- Mahalingam P, Topiwalla TT, Ganesan G. Vitreous rebleed following sutureless vitrectomy: Incidence and risk factors. Indian J Ophthalmol. 2018;66(4):558-61. [Crossref] [PubMed] [PMC]
- Cunningham AJ. Improving operating room productivity and efficiency-are there any simple strategies? Rom J Anaesth Intensive Care. 2017;24(2):87-8. [Crossref] [PubMed] [PMC]
- Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153(4):e176233. [Crossref] [PubMed] [PMC]
- Angermann R, Huber AL, Hofer M, Nowosielski Y, Egger S, Kralinger MT, et al. Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential factors. BMJ Open. 2021;11(12):e052513. [Crossref] [PubMed] [PMC]
- Mimouni M, Abualhasan H, Mtanes K, Mazzawi F, Barak Y. Patients' experience of anxiety and pain during retrobulbar injections prior to vitrectomy. J Ophthalmol. 2019;2019:8098765. [Crossref] [PubMed] [PMC]
.: İşlem Listesi